ARCHIVES

HCFA Firm Against Reimbursement For Patients In Clinical Trials, Lasagna Committee Hears

This article is from The Cancer Letter archive.

Vol. 15 No. 12 | March 24, 1989

Download PDF Visit The Full Archive

Related Articles

NCI To Fund More Than 1,000 Competing Grants Under FY 1992 Budget

November 22, 1991

ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial.

September 8, 2006

Pitot Supports Clearinghouse Modifications

January 20, 1978

Diabetes Associated With Greater Risk Of Cancer

December 28, 2007

NCI program announcement available, contract awards listed.

November 14, 2003

Lasagna Committee Report Advocates Faster Drug approval, Insurance Coverage For Investigational Drugs, Ancillary Costs

September 7, 1990